Research article · 21 Dec 2011
Research articlePublished 23 Aug 2021
Development and Validation of Reverse Phase High Performance Liquid Chromatographic Method for Quantitative Estimation of Lenvatinib in Capsule Dosage Form
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of the work is to develop a simple, accurate, precise, and reproducible Reverse Phase High Performance Liquid Chromatographic (RP- HPLC) method for the determination of anticancer drug Lenvatinib in capsule dosage form. Chromatography was carried out on an Inert Sustain C18 (250 mm*4.6 mm*5 μm) column with a mobile phase consisting of Water : Acetonitrile : Trifluoroacetic acid (60:40:0.1) v/v. The detection was carried out at 241 nm, 10 μl injection volume was selected with a flow rate of 0.8 ml/min. Retention time was found to be 4.15 minutes. Method was linear over the range of 10-100 μg/ml with regression coefficient 0.9991. The method was validated as per ICH guidelines. The developed method is superior in terms of theoretical plates and it has got less tailing factor. The method can be applied for routine quality control analysis of Lenvatinib in capsule formulation.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2011
Development and Validation of Reversed-Phase High Performance Liquid Chromatographic Method for Estimation of Sumatriptan Succinate In Pharmaceutical Dosage Form
Research article · 30 Nov 2013
A validated reverse phase high performance liquid chromatographic assay method for the estimation of iloperidone in bulk and commercial tablet dosage form
Article · 5 Apr 2024
Quality by Design Based Stability Indicating Quantitative Reverse Phase High Performance Liquid Chromatography Method Development and Validation for Bilastine in Tablet Dosage Form
Article · 20 Feb 2024
Analytical Method Development and Validation for Estimation of Emtricitabine in Tablet Dosage Form by Reverse Phase High Performance Liquid Chromatography
More from this journal
The newest in Research & Reviews: Journal of Pharmaceutics and Nanotechnology.
Editorial · 29 Dec 2025
Scale-Up and Manufacturing of Nanomedicines: From Laboratory Innovation to Commercial Production
Editorial · 29 Dec 2025
Nanotoxicity Assessment: Evaluating the Safety of Nanomaterials in Biomedical Applications
Editorial · 29 Dec 2025
Sustained and Controlled Release Formulations: Enhancing Therapeutic Efficacy and Patient Compliance
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalResearch & Reviews: Journal of Pharmaceutics and Nanotechnology
- SubjectPharmaceutical Sciences
- SubjectNanotechnology
- BylineArticles whose byline prints “Priya Temgire”
